Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
16 November 2021 - 8:05AM
Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage
regenerative medicine company focused on creating the next
generation of differentiated products and improving outcomes in
patients undergoing surgery, today announced the company will
participate in two upcoming virtual investor conferences.
Event: Canaccord Genuity Virtual MedTech, Diagnostics
and Digital Health & Services ForumFormat: 1x1
MeetingsDate: Thursday, November 18, 2021
Event: 33rd Annual
Piper Sandler Healthcare Conference Format: Fireside Chat
and 1x1 meetingsDate: Members of the management team will be
participating in investor meetings on Thursday, December 2, 2021. A
pre-recorded Fireside Chat will be available beginning Monday,
November 22nd at 7:00AM PT / 10:00AM ET on the “Investors” section
of the Company’s website at www.Aziyo.com.
About Aziyo Biologics Aziyo Biologics is a
commercial-stage regenerative medicine company focused on creating
the next generation of differentiated products and improving
outcomes in patients undergoing surgery, concentrating on patients
receiving implantable medical devices. Since its founding in 2015,
the Company has created a portfolio of commercial-stage products
used in cardiovascular, orthopedic, and reconstructive specialties.
For more information, visit
www.Aziyo.com.
Media:Courtney GuyerAziyo Biologics,
Inc.PR@aziyo.com
Investors:Leigh Salvo Gilmartin
Groupinvestors@aziyo.com
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aziyo Biologics (NASDAQ:AZYO)
Historical Stock Chart
From Apr 2023 to Apr 2024